Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

Alzheimer's is the most common cause of dementia, a general term for memory loss and other cognitive abilities serious enough ...

such as Alzheimer’s disease: These medications are called anti-amyloid treatments. They work by removing beta-amyloid, a protein that can build up in your brain and contribute to neuron loss.

Two novel drugs for treating Alzheimer's have been rejected for use on the NHS, despite gaining approval from the UK ...

Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

New treatments for Alzheimer disease don’t reverse cognitive symptoms, but they do significantly slow progression. Evidence suggests that earlier treatment is most effective. In his first ...

The Alzheimer's Association says more than 122,000 Missourians 65 years and older are battling Alzheimer's Disease, which has ...

Andrew Fein has given his Buy rating due to a combination of factors related to Alector’s promising developments in their Alzheimer’s treatments. A significant number of participants from the INVOKE-2 ...

At the end of October, Nice declined to approve this drug for use on the NHS for treating early-stage Alzheimer's disease.

Health system changes that bolster access to disease-modifying treatments for Alzheimer’s disease could reduce the disparities in diagnosis and improve health equity in disease treatment overall, ...

A recent study reveals that a polymer called polyphosphate may stabilize fibrils, protein structures linked to Alzheimer's, Parkinson's, and other neurodegenerative diseases. Researchers used computer ...

The Alzheimer's Association says more than 122,000 Missourians 65 years and older are battling Alzheimer's Disease, which has been documented for nearly 120 years. In that time, multiple ...